Natural polyphenolic inhibitors against the antiapoptotic BCL-2

Sharad Verma1, Aditi Singh2, Anchala Kumari2

  • 1a School of Biotechnology , Jawaharlal Nehru University , New Delhi , India.

Insights

Polyphenols like luteolin and fisetin show potential as cancer treatments by inhibiting BCL-2, a protein linked to cancer progression and chemotherapy resistance. These natural compounds offer a promising avenue for developing new anti-cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • The BCL-2 protein family regulates apoptosis, a critical cellular process.
  • Overexpression of BCL-2 is implicated in cancer development and resistance to chemotherapy.

Purpose of the Study:

  • To investigate the potential of specific polyphenols as inhibitors of BCL-2.
  • To explore the binding interactions between selected polyphenols and BCL-2.

Main Methods:

  • Molecular dynamics (MD) simulations were employed to analyze the binding of polyphenols to BCL-2.
  • Van der Waals (vdW) energy and LigPlot analysis were used to assess interaction stability and identify critical interactions.

Main Results:

  • All tested polyphenols (apigenin, fisetin, galangin, luteolin) stably bound to the hydrophobic groove of BCL-2.
  • Luteolin exhibited the highest binding affinity, followed by fisetin, indicating potent BCL-2 inhibition.
  • Hydrophobic interactions were identified as crucial for the stable complex formation between polyphenols and BCL-2.

Conclusions:

  • The studied polyphenols demonstrate potential as lead compounds for developing novel BCL-2 inhibitors.
  • These findings suggest a therapeutic strategy targeting BCL-2 in cancer treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.1K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.4K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K